Two Sigma Investments’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Two Sigma Investments’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-146,348	Closed	-$14.1M	–	3759
2020 Q2	$14.1M	Buy	146,348 +27,345	+23%	+$2.28M	0.07%	294
2020 Q1	$5.58M	Buy	119,003 +98,503	+481%	+$6.31M	0.05%	456
2019 Q4	$1.49M	Buy	+20,500	New	+$1.24M	﹤0.01%	1830
2019 Q3	–	Sell	-21,562	Closed	-$1.08M	–	3934
2019 Q2	$1.08M	Buy	21,562 +5,962	+38%	+$290K	﹤0.01%	1883
2019 Q1	$811K	Buy	+15,600	New	+$719K	﹤0.01%	1953
2018 Q1	–	Sell	-15,420	Closed	-$649K	–	3687
2017 Q4	$649K	Sell	15,420 -74,475	-83%	-$2.87M	﹤0.01%	2261
2017 Q3	$3.85M	Buy	+89,895	New	+$2.87M	0.01%	928
2016 Q4	–	Sell	-11,879	Closed	-$194K	–	3653
2016 Q3	$194K	Buy	+11,879	New	+$214K	﹤0.01%	2960

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Two Sigma Investments's MYOK Position: Q3 2020 in Review

Two Sigma Investments sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 146,348 shares — an estimated $14.1M sold.

Two Sigma Investments first reported a position in MYOK in Q3 2016 and held it in 8 quarters. The position peaked at $14.1M in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

Two Sigma Investments reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Two Sigma Investments sold 146,348 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $14.1M.
Two Sigma Investments first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 8 quarters.
Two Sigma Investments's MyoKardia, Inc. Common Stock position peaked at $14.1M in Q2 2020.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Two Sigma Investments's 13F filing for Q3 2020, filed 16 Nov 2020.